Healthcare

Research and innovation addressing today's greatest health challenges

Dark Matter Matters: AI Makes DNA Dark Matter Useful

What is the minimal description that captures a space? Asking a mathematician’s basic question of a  biological dataset reveals interesting answers about biology itself. This summarizes our underlying approach to subtyping hematological cancer. Disease subtyping is a central tenet of precision medicine, and is the challenging task of identifying and classifying patients with similar presentations […]

Continue reading

Helping to Untangle Cancer Drug Resistance with Data

Why do targeted cancer therapies often fail? We have acquired so much more understanding about cancer in the last fifty years than in the last five thousand years. Approaches to patient treatments have dramatically changed, and statistics show significant improvement in patient response and outcomes to therapy in the last half a century [1]. Yet […]

Continue reading

Quantitative Immunohistochemistry: Adding new sight to a historic technique

Using microfluidic probe, IBM scientists perform microscale IHC on tissue sections with a gradient of incubation times for the primary antibody.

Continue reading

AI Models Predict Breast Cancer with Radiologist-Level Accuracy

Our team of IBM researchers published research in Radiology around a new AI model that can predict the development of malignant breast cancer in patients within the year, at rates comparable to human radiologists.

Continue reading

AI Offers Hope for Earlier Screening for Type 1 Diabetes

IBM researchers launch the first in-depth, large scale study of time courses when different antibodies appear, and their correlations to type 1 diabetes.

Continue reading

IBM and Johns Hopkins University School of Medicine Discover Unique, Pathogenic Autoimmune Cells in Type 1 Diabetes

Researchers at JHU and IBM identify new cells involved in the autoimmune attack on insulin-producing cells in type 1 diabetes.

Continue reading

Continuous-Flow Reactor Could Potentially Help Speed Drug Discovery

New continuous-flow approach to chemical synthesis holds promise in accelerating therapeutic discovery for drug-resistant infectious diseases and cancer.

Continue reading

Research Using IBM Cloud and AI Sheds Light on Huntington’s Disease (HD)

New research combining the power of brain modeling, IBM’s AI, and the IBM Cloud sheds light on how brain cells interact in Huntington’s disease.

Continue reading

Deciphering Breast Cancer Heterogeneity Using Machine Learning

A comprehensive analysis of tumor ecosystems that represents an important step in research that may lead to precision medicine approaches to treat breast cancer.

Continue reading

Exploring the Expressive Range of Conversational Laughter with AI

IBM scientists use crowdsourcing and AI techniques to explore what different types of conversational laughter can tell us.

Continue reading

AI Holds Promise for Glaucoma, a Leading Global Cause of Blindness

IBM Research and New York University are using AI to analyze retina imaging data and help to assess the presence of glaucoma.

Continue reading